Observation and nursing of eradication of Helicobacter pylori infection
GE Weiyuan
Abstract
GE Weiyuan
Abstract
Objective: To observe the three drug regimens eradication of Helicobacter pylori (Hp) infection therapy. Methods: 396 confirmed by endoscopy for chronic gastritis and peptic ulcer Hp-positive patients were randomly divided into three groups. Group 1, Omeprazole 20 mg+Clarithromycin 500 mg+Amoxicillin 1 000 mg, po, bid; group 2, Omeprazole 20 mg+ Amoxicillin 1 000 mg+Etronidazole 400 mg, po, bid; group 3, Omeprazole 20 mg+Amoxicillin 1 000 mg+Furazolidone 100 mg, po, bid. 132 cases in each group, there was a course of 7 days after treatment, were done within 7 days of outpatient and telephone follow-up, record adverse reaction after taking place. Results: Three groups of Hp eradication rates as, group 1 of 86.12%; group 2 of 59.23%; group 3 of 92.24%, there was no significant difference between group 1 and 3 (χ2=2.70, P0.05), there was a significant difference between group 1 and 2 (χ2=39.51,P0.01), group 3group 1group 2. Conclusion: A triple therapy method could have the role of Helicobacter pylori infection and no adverse reaction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the three drug regimens eradication of Helicobacter pylori (Hp) infection therapy. Methods: 396 confirmed by endoscopy for chronic gastritis and peptic ulcer Hp-positive patients were randomly divided into three groups. Group 1, Omeprazole 20 mg+Clarithromycin 500 mg+Amoxicillin 1 000 mg, po, bid; group 2, Omeprazole 20 mg+ Amoxicillin 1 000 mg+Etronidazole 400 mg, po, bid; group 3, Omeprazole 20 mg+Amoxicillin 1 000 mg+Furazolidone 100 mg, po, bid. 132 cases in each group, there was a course of 7 days after treatment, were done within 7 days of outpatient and telephone follow-up, record adverse reaction after taking place. Results: Three groups of Hp eradication rates as, group 1 of 86.12%; group 2 of 59.23%; group 3 of 92.24%, there was no significant difference between group 1 and 3 (χ2=2.70, P0.05), there was a significant difference between group 1 and 2 (χ2=39.51,P0.01), group 3group 1group 2. Conclusion: A triple therapy method could have the role of Helicobacter pylori infection and no adverse reaction.
Key concepts: Medicine, Omeprazole, Furazolidone, Amoxicillin, Helicobacter pylori, Gastroenterology, Internal medicine, Clarithromycin